Roota

Roota Bio is a Japanese biotechnology company specializing in the research and development of extracellular vesicles (EVs), including exosomes, for diagnostic and therapeutic applications. Founded in 2021 as a spin-off from Tokyo Medical University, the company leverages its proprietary platform to identify EV-based biomarkers for early cancer detection and to develop targeted drug delivery systems. Roota Bio's technology focuses on the isolation and analysis of EVs from liquid biopsies, aiming to provide non-invasive precision medicine solutions. The company is currently advancing its pre-clinical pipeline, which includes both diagnostic tools and therapeutic candidates primarily focused on oncology.